Blood clots are among the most preventable causes of harm in hospitals, yet anticoagulant supply chains face constant pressure from aging patients, chronic disease and price competition. Heparin calcium, a long-established anticoagulant, sits at the center of that tension. According to Polaris Market Research, the global Heparin Calcium market was valued at USD 1,466.95 million in 2023 and is...
